Merck Global Health Innovation Fund is a venture capital firm in Whitehouse Station that prefers to invest in emerging healthcare technology companies. Founded 2010 in Whitehouse Station, New Jersey, the firm invests in Series B, Series D, Series C, and Series E rounds. The notable investment portfolio of Merck Global Health Innovation Fund includes PathAI, Navigating Cancer, Ciox Health, and GenomeDx Biosciences. As of January 2020, Merck Global Health Innovation Fund has made 57 investments and 14 exits. Their most recent investment was on Nov 4, 2019, when PathAI raised $15M.
David M. Rubin
Francesca Domenech Wuttke
Managing Director and Head of Venture Investments
Documentaries, videos and podcasts